Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
Supporting India during the devastating coronavirus surge
Like many others around the world, America ’s biopharmaceutical companies stand with those affected by the coronavirus. And while biopharmaceutical companies areworking around the clock to meet the demands of COVID-19 by developing and delivering therapeutics and vaccines, we recognize that the coronavirus crisis in India requires urgent attention and collaborative solutions from stakeholders globally.
Source: The Catalyst - May 20, 2021 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Vaccines Coronavirus Source Type: news
America ’s biopharmaceutical companies are working around the clock to beat coronavirus
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry ’scommitment to finding solutions to prevent, diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. The decades-long investments biopharmaceutical companies have made in new technologies, research and treatments have prepared the industry to act swiftly to respond to the public health crisis.
Source: The Catalyst - March 20, 2020 Category: Pharmaceuticals Tags: Research and Development PhRMA Member Company Clinical Trials Infectious Diseases Coronavirus Source Type: news
ICYMI: America ’s biopharmaceutical companies are working 'around the clock' to beat coronavirus
Recently, PhRMA hosted a teleconference to provide an update on our member companies ’ around-the-clock efforts in developing treatments and vaccines for COVID-19, a disease caused by a novel coronavirus. PhRMA president and CEO Steve Ubl led the conversation and was joined by Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfiz er, Clement Lewin, Ph.D., associate vice president Head BARDA Office and NV Stakeholder Engagement, Sanofi, Thomas Breuer, MD, MSc., senior vice president, chief medical officer, GSK Vaccines, Julie Kim, president of Plasma-Derived Therapies, T...
Source: The Catalyst - April 1, 2020 Category: Pharmaceuticals Authors: Gabby Migliara Tags: Research and Development PhRMA Member Company Coronavirus Source Type: news
Is The Coronavirus Really Losing Potency In Italy? What You Need To Know
Here is what a doctor in Italy claimed about the Covid-19 coronavirus and what experts from the World Health Organization (WHO) said in response.
Source: Forbes.com Healthcare News - June 2, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus business pharma Source Type: news
Moderna Hires New CFO Amid Race To Develop Coronavirus Treatment
Biotech company Moderna, which is among the leaders in the race to develop a coronavirus vaccine, on Thursday named a sector veteran its new finance chief, as it gears up to launch commercial operations and potentially oversee explosive growth if it succeeds in releasing a Covid-19 treatment.
Source: Forbes.com Healthcare News - June 4, 2020 Category: Pharmaceuticals Authors: Ezequiel Minaya, Forbes Staff Tags: CFO Network /cfo-network Leadership /leadership Innovation /innovation Healthcare /healthcare Science /science Business /business Editors' Pick editors-pick Coronavirus Source Type: news
What Coronavirus Can Teach Us About Risk In Healthcare
The biggest barrier to moving toward a value-based at-risk model has been executives ’ fear of potential loss if they move away from fee-for-service. But the coronavirus has taught us that the potential for loss in fee-for-service is bottomless.
Source: Forbes.com Healthcare News - June 5, 2020 Category: Pharmaceuticals Authors: Rita Numerof, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Source Type: news
Tear Gas And Pepper Spray Can Maim, Kill And Spread Coronavirus
Despite denials from AG Barr, pepper spray and tear gas are dangerous chemicals being used against protesters. They will likely worsen the coronavirus epidemic.
Source: Forbes.com Healthcare News - June 8, 2020 Category: Pharmaceuticals Authors: Judy Stone, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news
New Study Shows Hydroxychloroquine Doesn ’t Prevent Covid-19 Coronavirus Infection
Virus expert Dave Wessner explores a new study that shows that hydroxychloroquine doesn ’t appear to prevent people from being infected with the coronavirus that causes Covid-19.
Source: Forbes.com Healthcare News - June 9, 2020 Category: Pharmaceuticals Authors: Dave Wessner, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news
Silver Lining to Coronavirus Crisis: Telehealth May Improve Patient Adherence And Persistence
The coronavirus crisis has been a catalyst in substantially broadening telehealth services and reimbursement. With patient non-adherence to prescription regimens still stuck at as high as 50% telehealth may offer a path forward to effectively address this problem.
Source: Forbes.com Healthcare News - June 9, 2020 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
Early Data From Coronavirus Vaccine Trials Are Encouraging, But There ’s Still A Long Way To Go
Virologist Dave Wessner explains what we know about two promising coronavirus vaccines so far - and how much more we still need to know before they come onto the market.
Source: Forbes.com Healthcare News - June 11, 2020 Category: Pharmaceuticals Authors: Dave Wessner, Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news
Trump Urges Healthcare Facilities To Re-Open Where There ’s ‘No Evidence’ Of A Coronavirus Rebound
The Trump administration Tuesday issued guidelines for healthcare facilities on how to re-open to serve patients in “states and regions with no evidence of a rebound” of the coronavirus strain Covid-19.
Source: Forbes.com Healthcare News - June 9, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Policy /policy Editors' Pick editors-pick Coronavirus pharma Source Type: news
New York Has Lowest Coronavirus Spread Rate In The Nation, Cuomo Says
"We ’re at a pivotal point" in the fight against coronavirus, Cuomo said.
Source: Forbes.com Healthcare News - June 12, 2020 Category: Pharmaceuticals Authors: Sergei Klebnikov, Forbes Staff Tags: Markets /markets Money /money Business /business Innovation /innovation Healthcare /healthcare Leadership /leadership Personal Finance /personal-finance Breaking breaking-news Coronavirus Source Type: news
Is Eating Meat From Meatpacking Plants With Covid-19 Coronavirus Outbreaks Safe?
Hundreds of meatpacking plants in the U.S. have experienced coronavirus outbreaks. Is eating meat processed by these plants safe?
Source: Forbes.com Healthcare News - June 21, 2020 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus business pharma & Source Type: news
Infected India: The True Toll Of Coronavirus In The World ’s 2nd-Most Populated Country
In a densely populated land of nearly 1.4 billion people, the coronavirus is about to wreak unprecedented havoc in India. But measures - old and new - may curtail the damage.
Source: Forbes.com Healthcare News - June 26, 2020 Category: Pharmaceuticals Authors: Lipi Roy, MD, MPH, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
Rite Aid ’s Coronavirus Safety Costs Overshadow Big Jump In Sales
Rite Aid saw a big jump in overall sales as cases of the coronavirus strain Covid-19 surged this spring, but costs of protecting employees and customers hit profits in the drugstore chain ’s first quarter, the company said Thursday.
Source: Forbes.com Healthcare News - June 25, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Retail /retail Editors' Pick editors-pick Coronavirus pharma Source Type: news
